RMTI Stock Summary and Trading Ideas (Rockwell Medical | NASDAQ:RMTI)

Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, and acid and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate among others.

Rockwell Medical trades on the NASDAQ stock market under the symbol RMTI.

As of February 13, 2026, RMTI stock price declined to $1.01 with 132,457 million shares trading.

RMTI has a beta of 1.05, meaning it tends to be more sensitive to market movements. RMTI has a correlation of 0.05 to the broad based SPY ETF.

RMTI has a market cap of $39.80 million. This is considered a Sub-Micro Cap stock.

Last quarter Rockwell Medical reported $16 million in Revenue and $.00 earnings per share. This fell short of revenue expectation by $-537,600 and exceeded earnings estimates by $.04.

In the last 3 years, RMTI traded as high as $6.24 and as low as $.78.

The top ETF exchange traded funds that RMTI belongs to (by Net Assets): VTI, VXF, IWC.

RMTI has underperformed the market in the last year with a price return of -45.7% while the SPY ETF gained +13.0%. However, in the short term, RMTI had mixed performance relative to the market. It has outperformed in the last 3 months, returning +10.7% vs +1.7% return in SPY. But in the last 2 weeks, RMTI shares have been beat by the market, returning -5.6% compared to an SPY return of -1.5%.

RMTI support price is $.96 and resistance is $1.08 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that RMTI shares will trade within this expected range on the day.